INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1005031, encodeId=899f100503136, content=偏重的研究方向：分子生物学 经验分享：7.31提交，目前Pending review 三天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Wed Aug 04 07:12:27 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015572, encodeId=718e10155e2cb, content=偏重的研究方向：肿瘤 经验分享：6月收到约稿，开始准备稿件，准备过程中看有人说有医院单位就不收，我是通讯（高校），一作是医院同事，怕浪费时间，我就邮件问了一下编辑，她说不会歧视的。然后我就开心的投了过去，第三天毫无理由就拒了……我……简直无言以对…… 所以，医院的同僚们放弃这个杂志吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZBFMhfUxWGFlC0H0yG1ibTnKxgXEYfA4remwtQ8Y1W5l5EwnxawChADQpPHFvZibrJMezsFEQgR7soXFY85NlmeQ/132, createdBy=41d22323925, createdName=坐敷锦, createdTime=Wed Sep 08 09:18:37 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082246, encodeId=6c7f1082246fd, content=Pending editor decision 10天了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06432490800, createdName=1247a584m21(暂无昵称), createdTime=Mon Dec 20 22:27:15 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210841, encodeId=3e3712108415f, content=Pending review第三天了。是不是要凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Wed Apr 13 13:15:42 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803510, encodeId=21008035100b, content=真的是秒拒，还不写原因。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecdd1390758, createdName=hech55, createdTime=Mon Jul 20 17:49:35 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121765, encodeId=a8872121e658e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;细胞生物学 经验分享：1月底号投稿，2月底大修，2个审稿人提了70多个问题，审稿人问题非常专业。10天未能修完，申请延迟2周修完返稿。25号二轮小修，等待结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53428363497, createdName=ms1000001887278650, createdTime=Sat Mar 25 16:01:23 CST 2023, time=2023-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1235050, encodeId=b465123505005, content=7.7投出 7.19给大修 7.26晚刚修回希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e7a6477083, createdName=ms4000000109314509, createdTime=Wed Jul 27 14:04:55 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957595, encodeId=5e3c95e59554, content=pending review已经六天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/49E1220F4F23D52CFAD7CD6EFB4CD4A2/100, createdBy=97fc2126613, createdName=吹散的天空, createdTime=Fri Apr 16 15:20:06 CST 2021, time=2021-04-16, status=1, ipAttribution=)]

2021-08-04 努力yy

偏重的研究方向：分子生物学
经验分享：7.31提交，目前Pending review 三天了

112 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005031, encodeId=899f100503136, content=偏重的研究方向：分子生物学 经验分享：7.31提交，目前Pending review 三天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Wed Aug 04 07:12:27 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015572, encodeId=718e10155e2cb, content=偏重的研究方向：肿瘤 经验分享：6月收到约稿，开始准备稿件，准备过程中看有人说有医院单位就不收，我是通讯（高校），一作是医院同事，怕浪费时间，我就邮件问了一下编辑，她说不会歧视的。然后我就开心的投了过去，第三天毫无理由就拒了……我……简直无言以对…… 所以，医院的同僚们放弃这个杂志吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZBFMhfUxWGFlC0H0yG1ibTnKxgXEYfA4remwtQ8Y1W5l5EwnxawChADQpPHFvZibrJMezsFEQgR7soXFY85NlmeQ/132, createdBy=41d22323925, createdName=坐敷锦, createdTime=Wed Sep 08 09:18:37 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082246, encodeId=6c7f1082246fd, content=Pending editor decision 10天了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06432490800, createdName=1247a584m21(暂无昵称), createdTime=Mon Dec 20 22:27:15 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210841, encodeId=3e3712108415f, content=Pending review第三天了。是不是要凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Wed Apr 13 13:15:42 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803510, encodeId=21008035100b, content=真的是秒拒，还不写原因。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecdd1390758, createdName=hech55, createdTime=Mon Jul 20 17:49:35 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121765, encodeId=a8872121e658e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;细胞生物学 经验分享：1月底号投稿，2月底大修，2个审稿人提了70多个问题，审稿人问题非常专业。10天未能修完，申请延迟2周修完返稿。25号二轮小修，等待结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53428363497, createdName=ms1000001887278650, createdTime=Sat Mar 25 16:01:23 CST 2023, time=2023-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1235050, encodeId=b465123505005, content=7.7投出 7.19给大修 7.26晚刚修回希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e7a6477083, createdName=ms4000000109314509, createdTime=Wed Jul 27 14:04:55 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957595, encodeId=5e3c95e59554, content=pending review已经六天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/49E1220F4F23D52CFAD7CD6EFB4CD4A2/100, createdBy=97fc2126613, createdName=吹散的天空, createdTime=Fri Apr 16 15:20:06 CST 2021, time=2021-04-16, status=1, ipAttribution=)]

2021-09-08 坐敷锦

偏重的研究方向：肿瘤
经验分享：6月收到约稿，开始准备稿件，准备过程中看有人说有医院单位就不收，我是通讯（高校），一作是医院同事，怕浪费时间，我就邮件问了一下编辑，她说不会歧视的。然后我就开心的投了过去，第三天毫无理由就拒了……我……简直无言以对…… 所以，医院的同僚们放弃这个杂志吧……

103 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005031, encodeId=899f100503136, content=偏重的研究方向：分子生物学 经验分享：7.31提交，目前Pending review 三天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Wed Aug 04 07:12:27 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015572, encodeId=718e10155e2cb, content=偏重的研究方向：肿瘤 经验分享：6月收到约稿，开始准备稿件，准备过程中看有人说有医院单位就不收，我是通讯（高校），一作是医院同事，怕浪费时间，我就邮件问了一下编辑，她说不会歧视的。然后我就开心的投了过去，第三天毫无理由就拒了……我……简直无言以对…… 所以，医院的同僚们放弃这个杂志吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZBFMhfUxWGFlC0H0yG1ibTnKxgXEYfA4remwtQ8Y1W5l5EwnxawChADQpPHFvZibrJMezsFEQgR7soXFY85NlmeQ/132, createdBy=41d22323925, createdName=坐敷锦, createdTime=Wed Sep 08 09:18:37 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082246, encodeId=6c7f1082246fd, content=Pending editor decision 10天了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06432490800, createdName=1247a584m21(暂无昵称), createdTime=Mon Dec 20 22:27:15 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210841, encodeId=3e3712108415f, content=Pending review第三天了。是不是要凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Wed Apr 13 13:15:42 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803510, encodeId=21008035100b, content=真的是秒拒，还不写原因。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecdd1390758, createdName=hech55, createdTime=Mon Jul 20 17:49:35 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121765, encodeId=a8872121e658e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;细胞生物学 经验分享：1月底号投稿，2月底大修，2个审稿人提了70多个问题，审稿人问题非常专业。10天未能修完，申请延迟2周修完返稿。25号二轮小修，等待结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53428363497, createdName=ms1000001887278650, createdTime=Sat Mar 25 16:01:23 CST 2023, time=2023-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1235050, encodeId=b465123505005, content=7.7投出 7.19给大修 7.26晚刚修回希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e7a6477083, createdName=ms4000000109314509, createdTime=Wed Jul 27 14:04:55 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957595, encodeId=5e3c95e59554, content=pending review已经六天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/49E1220F4F23D52CFAD7CD6EFB4CD4A2/100, createdBy=97fc2126613, createdName=吹散的天空, createdTime=Fri Apr 16 15:20:06 CST 2021, time=2021-04-16, status=1, ipAttribution=)]

2022-10-14 148609fcm78暂无昵称

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：机制;肿瘤;信号通路
经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗

130 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005031, encodeId=899f100503136, content=偏重的研究方向：分子生物学 经验分享：7.31提交，目前Pending review 三天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Wed Aug 04 07:12:27 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015572, encodeId=718e10155e2cb, content=偏重的研究方向：肿瘤 经验分享：6月收到约稿，开始准备稿件，准备过程中看有人说有医院单位就不收，我是通讯（高校），一作是医院同事，怕浪费时间，我就邮件问了一下编辑，她说不会歧视的。然后我就开心的投了过去，第三天毫无理由就拒了……我……简直无言以对…… 所以，医院的同僚们放弃这个杂志吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZBFMhfUxWGFlC0H0yG1ibTnKxgXEYfA4remwtQ8Y1W5l5EwnxawChADQpPHFvZibrJMezsFEQgR7soXFY85NlmeQ/132, createdBy=41d22323925, createdName=坐敷锦, createdTime=Wed Sep 08 09:18:37 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082246, encodeId=6c7f1082246fd, content=Pending editor decision 10天了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06432490800, createdName=1247a584m21(暂无昵称), createdTime=Mon Dec 20 22:27:15 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210841, encodeId=3e3712108415f, content=Pending review第三天了。是不是要凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Wed Apr 13 13:15:42 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803510, encodeId=21008035100b, content=真的是秒拒，还不写原因。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecdd1390758, createdName=hech55, createdTime=Mon Jul 20 17:49:35 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121765, encodeId=a8872121e658e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;细胞生物学 经验分享：1月底号投稿，2月底大修，2个审稿人提了70多个问题，审稿人问题非常专业。10天未能修完，申请延迟2周修完返稿。25号二轮小修，等待结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53428363497, createdName=ms1000001887278650, createdTime=Sat Mar 25 16:01:23 CST 2023, time=2023-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1235050, encodeId=b465123505005, content=7.7投出 7.19给大修 7.26晚刚修回希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e7a6477083, createdName=ms4000000109314509, createdTime=Wed Jul 27 14:04:55 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957595, encodeId=5e3c95e59554, content=pending review已经六天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/49E1220F4F23D52CFAD7CD6EFB4CD4A2/100, createdBy=97fc2126613, createdName=吹散的天空, createdTime=Fri Apr 16 15:20:06 CST 2021, time=2021-04-16, status=1, ipAttribution=)]

2021-12-20 1247a584m21(暂无昵称)

Pending editor decision 10天了，怎么办

84 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005031, encodeId=899f100503136, content=偏重的研究方向：分子生物学 经验分享：7.31提交，目前Pending review 三天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Wed Aug 04 07:12:27 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015572, encodeId=718e10155e2cb, content=偏重的研究方向：肿瘤 经验分享：6月收到约稿，开始准备稿件，准备过程中看有人说有医院单位就不收，我是通讯（高校），一作是医院同事，怕浪费时间，我就邮件问了一下编辑，她说不会歧视的。然后我就开心的投了过去，第三天毫无理由就拒了……我……简直无言以对…… 所以，医院的同僚们放弃这个杂志吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZBFMhfUxWGFlC0H0yG1ibTnKxgXEYfA4remwtQ8Y1W5l5EwnxawChADQpPHFvZibrJMezsFEQgR7soXFY85NlmeQ/132, createdBy=41d22323925, createdName=坐敷锦, createdTime=Wed Sep 08 09:18:37 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082246, encodeId=6c7f1082246fd, content=Pending editor decision 10天了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06432490800, createdName=1247a584m21(暂无昵称), createdTime=Mon Dec 20 22:27:15 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210841, encodeId=3e3712108415f, content=Pending review第三天了。是不是要凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Wed Apr 13 13:15:42 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803510, encodeId=21008035100b, content=真的是秒拒，还不写原因。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecdd1390758, createdName=hech55, createdTime=Mon Jul 20 17:49:35 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121765, encodeId=a8872121e658e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;细胞生物学 经验分享：1月底号投稿，2月底大修，2个审稿人提了70多个问题，审稿人问题非常专业。10天未能修完，申请延迟2周修完返稿。25号二轮小修，等待结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53428363497, createdName=ms1000001887278650, createdTime=Sat Mar 25 16:01:23 CST 2023, time=2023-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1235050, encodeId=b465123505005, content=7.7投出 7.19给大修 7.26晚刚修回希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e7a6477083, createdName=ms4000000109314509, createdTime=Wed Jul 27 14:04:55 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957595, encodeId=5e3c95e59554, content=pending review已经六天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/49E1220F4F23D52CFAD7CD6EFB4CD4A2/100, createdBy=97fc2126613, createdName=吹散的天空, createdTime=Fri Apr 16 15:20:06 CST 2021, time=2021-04-16, status=1, ipAttribution=)]

2022-04-13 ms1000001833329884

Pending review第三天了。是不是要凉凉了

61 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005031, encodeId=899f100503136, content=偏重的研究方向：分子生物学 经验分享：7.31提交，目前Pending review 三天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Wed Aug 04 07:12:27 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015572, encodeId=718e10155e2cb, content=偏重的研究方向：肿瘤 经验分享：6月收到约稿，开始准备稿件，准备过程中看有人说有医院单位就不收，我是通讯（高校），一作是医院同事，怕浪费时间，我就邮件问了一下编辑，她说不会歧视的。然后我就开心的投了过去，第三天毫无理由就拒了……我……简直无言以对…… 所以，医院的同僚们放弃这个杂志吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZBFMhfUxWGFlC0H0yG1ibTnKxgXEYfA4remwtQ8Y1W5l5EwnxawChADQpPHFvZibrJMezsFEQgR7soXFY85NlmeQ/132, createdBy=41d22323925, createdName=坐敷锦, createdTime=Wed Sep 08 09:18:37 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082246, encodeId=6c7f1082246fd, content=Pending editor decision 10天了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06432490800, createdName=1247a584m21(暂无昵称), createdTime=Mon Dec 20 22:27:15 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210841, encodeId=3e3712108415f, content=Pending review第三天了。是不是要凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Wed Apr 13 13:15:42 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803510, encodeId=21008035100b, content=真的是秒拒，还不写原因。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecdd1390758, createdName=hech55, createdTime=Mon Jul 20 17:49:35 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121765, encodeId=a8872121e658e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;细胞生物学 经验分享：1月底号投稿，2月底大修，2个审稿人提了70多个问题，审稿人问题非常专业。10天未能修完，申请延迟2周修完返稿。25号二轮小修，等待结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53428363497, createdName=ms1000001887278650, createdTime=Sat Mar 25 16:01:23 CST 2023, time=2023-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1235050, encodeId=b465123505005, content=7.7投出 7.19给大修 7.26晚刚修回希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e7a6477083, createdName=ms4000000109314509, createdTime=Wed Jul 27 14:04:55 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957595, encodeId=5e3c95e59554, content=pending review已经六天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/49E1220F4F23D52CFAD7CD6EFB4CD4A2/100, createdBy=97fc2126613, createdName=吹散的天空, createdTime=Fri Apr 16 15:20:06 CST 2021, time=2021-04-16, status=1, ipAttribution=)]

2020-07-20 hech55

真的是秒拒，还不写原因。

295 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005031, encodeId=899f100503136, content=偏重的研究方向：分子生物学 经验分享：7.31提交，目前Pending review 三天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Wed Aug 04 07:12:27 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015572, encodeId=718e10155e2cb, content=偏重的研究方向：肿瘤 经验分享：6月收到约稿，开始准备稿件，准备过程中看有人说有医院单位就不收，我是通讯（高校），一作是医院同事，怕浪费时间，我就邮件问了一下编辑，她说不会歧视的。然后我就开心的投了过去，第三天毫无理由就拒了……我……简直无言以对…… 所以，医院的同僚们放弃这个杂志吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZBFMhfUxWGFlC0H0yG1ibTnKxgXEYfA4remwtQ8Y1W5l5EwnxawChADQpPHFvZibrJMezsFEQgR7soXFY85NlmeQ/132, createdBy=41d22323925, createdName=坐敷锦, createdTime=Wed Sep 08 09:18:37 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082246, encodeId=6c7f1082246fd, content=Pending editor decision 10天了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06432490800, createdName=1247a584m21(暂无昵称), createdTime=Mon Dec 20 22:27:15 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210841, encodeId=3e3712108415f, content=Pending review第三天了。是不是要凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Wed Apr 13 13:15:42 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803510, encodeId=21008035100b, content=真的是秒拒，还不写原因。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecdd1390758, createdName=hech55, createdTime=Mon Jul 20 17:49:35 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121765, encodeId=a8872121e658e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;细胞生物学 经验分享：1月底号投稿，2月底大修，2个审稿人提了70多个问题，审稿人问题非常专业。10天未能修完，申请延迟2周修完返稿。25号二轮小修，等待结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53428363497, createdName=ms1000001887278650, createdTime=Sat Mar 25 16:01:23 CST 2023, time=2023-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1235050, encodeId=b465123505005, content=7.7投出 7.19给大修 7.26晚刚修回希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e7a6477083, createdName=ms4000000109314509, createdTime=Wed Jul 27 14:04:55 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957595, encodeId=5e3c95e59554, content=pending review已经六天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/49E1220F4F23D52CFAD7CD6EFB4CD4A2/100, createdBy=97fc2126613, createdName=吹散的天空, createdTime=Fri Apr 16 15:20:06 CST 2021, time=2021-04-16, status=1, ipAttribution=)]

2023-03-25 ms1000001887278650 来自湖北省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：分子生物学;细胞生物学
经验分享：1月底号投稿，2月底大修，2个审稿人提了70多个问题，审稿人问题非常专业。10天未能修完，申请延迟2周修完返稿。25号二轮小修，等待结果。

78 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005031, encodeId=899f100503136, content=偏重的研究方向：分子生物学 经验分享：7.31提交，目前Pending review 三天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Wed Aug 04 07:12:27 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015572, encodeId=718e10155e2cb, content=偏重的研究方向：肿瘤 经验分享：6月收到约稿，开始准备稿件，准备过程中看有人说有医院单位就不收，我是通讯（高校），一作是医院同事，怕浪费时间，我就邮件问了一下编辑，她说不会歧视的。然后我就开心的投了过去，第三天毫无理由就拒了……我……简直无言以对…… 所以，医院的同僚们放弃这个杂志吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZBFMhfUxWGFlC0H0yG1ibTnKxgXEYfA4remwtQ8Y1W5l5EwnxawChADQpPHFvZibrJMezsFEQgR7soXFY85NlmeQ/132, createdBy=41d22323925, createdName=坐敷锦, createdTime=Wed Sep 08 09:18:37 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082246, encodeId=6c7f1082246fd, content=Pending editor decision 10天了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06432490800, createdName=1247a584m21(暂无昵称), createdTime=Mon Dec 20 22:27:15 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210841, encodeId=3e3712108415f, content=Pending review第三天了。是不是要凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Wed Apr 13 13:15:42 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803510, encodeId=21008035100b, content=真的是秒拒，还不写原因。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecdd1390758, createdName=hech55, createdTime=Mon Jul 20 17:49:35 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121765, encodeId=a8872121e658e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;细胞生物学 经验分享：1月底号投稿，2月底大修，2个审稿人提了70多个问题，审稿人问题非常专业。10天未能修完，申请延迟2周修完返稿。25号二轮小修，等待结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53428363497, createdName=ms1000001887278650, createdTime=Sat Mar 25 16:01:23 CST 2023, time=2023-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1235050, encodeId=b465123505005, content=7.7投出 7.19给大修 7.26晚刚修回希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e7a6477083, createdName=ms4000000109314509, createdTime=Wed Jul 27 14:04:55 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957595, encodeId=5e3c95e59554, content=pending review已经六天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/49E1220F4F23D52CFAD7CD6EFB4CD4A2/100, createdBy=97fc2126613, createdName=吹散的天空, createdTime=Fri Apr 16 15:20:06 CST 2021, time=2021-04-16, status=1, ipAttribution=)]

2023-04-02 sci快到碗里来来自四川省

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：神经科学;医学
经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，

65 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005031, encodeId=899f100503136, content=偏重的研究方向：分子生物学 经验分享：7.31提交，目前Pending review 三天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Wed Aug 04 07:12:27 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015572, encodeId=718e10155e2cb, content=偏重的研究方向：肿瘤 经验分享：6月收到约稿，开始准备稿件，准备过程中看有人说有医院单位就不收，我是通讯（高校），一作是医院同事，怕浪费时间，我就邮件问了一下编辑，她说不会歧视的。然后我就开心的投了过去，第三天毫无理由就拒了……我……简直无言以对…… 所以，医院的同僚们放弃这个杂志吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZBFMhfUxWGFlC0H0yG1ibTnKxgXEYfA4remwtQ8Y1W5l5EwnxawChADQpPHFvZibrJMezsFEQgR7soXFY85NlmeQ/132, createdBy=41d22323925, createdName=坐敷锦, createdTime=Wed Sep 08 09:18:37 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082246, encodeId=6c7f1082246fd, content=Pending editor decision 10天了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06432490800, createdName=1247a584m21(暂无昵称), createdTime=Mon Dec 20 22:27:15 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210841, encodeId=3e3712108415f, content=Pending review第三天了。是不是要凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Wed Apr 13 13:15:42 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803510, encodeId=21008035100b, content=真的是秒拒，还不写原因。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecdd1390758, createdName=hech55, createdTime=Mon Jul 20 17:49:35 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121765, encodeId=a8872121e658e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;细胞生物学 经验分享：1月底号投稿，2月底大修，2个审稿人提了70多个问题，审稿人问题非常专业。10天未能修完，申请延迟2周修完返稿。25号二轮小修，等待结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53428363497, createdName=ms1000001887278650, createdTime=Sat Mar 25 16:01:23 CST 2023, time=2023-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1235050, encodeId=b465123505005, content=7.7投出 7.19给大修 7.26晚刚修回希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e7a6477083, createdName=ms4000000109314509, createdTime=Wed Jul 27 14:04:55 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957595, encodeId=5e3c95e59554, content=pending review已经六天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/49E1220F4F23D52CFAD7CD6EFB4CD4A2/100, createdBy=97fc2126613, createdName=吹散的天空, createdTime=Fri Apr 16 15:20:06 CST 2021, time=2021-04-16, status=1, ipAttribution=)]

2022-07-27 ms4000000109314509

7.7投出 7.19给大修 7.26晚刚修回希望有个好结果

61 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005031, encodeId=899f100503136, content=偏重的研究方向：分子生物学 经验分享：7.31提交，目前Pending review 三天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Wed Aug 04 07:12:27 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015572, encodeId=718e10155e2cb, content=偏重的研究方向：肿瘤 经验分享：6月收到约稿，开始准备稿件，准备过程中看有人说有医院单位就不收，我是通讯（高校），一作是医院同事，怕浪费时间，我就邮件问了一下编辑，她说不会歧视的。然后我就开心的投了过去，第三天毫无理由就拒了……我……简直无言以对…… 所以，医院的同僚们放弃这个杂志吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZBFMhfUxWGFlC0H0yG1ibTnKxgXEYfA4remwtQ8Y1W5l5EwnxawChADQpPHFvZibrJMezsFEQgR7soXFY85NlmeQ/132, createdBy=41d22323925, createdName=坐敷锦, createdTime=Wed Sep 08 09:18:37 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082246, encodeId=6c7f1082246fd, content=Pending editor decision 10天了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06432490800, createdName=1247a584m21(暂无昵称), createdTime=Mon Dec 20 22:27:15 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210841, encodeId=3e3712108415f, content=Pending review第三天了。是不是要凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Wed Apr 13 13:15:42 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803510, encodeId=21008035100b, content=真的是秒拒，还不写原因。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecdd1390758, createdName=hech55, createdTime=Mon Jul 20 17:49:35 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121765, encodeId=a8872121e658e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;细胞生物学 经验分享：1月底号投稿，2月底大修，2个审稿人提了70多个问题，审稿人问题非常专业。10天未能修完，申请延迟2周修完返稿。25号二轮小修，等待结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53428363497, createdName=ms1000001887278650, createdTime=Sat Mar 25 16:01:23 CST 2023, time=2023-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1235050, encodeId=b465123505005, content=7.7投出 7.19给大修 7.26晚刚修回希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e7a6477083, createdName=ms4000000109314509, createdTime=Wed Jul 27 14:04:55 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957595, encodeId=5e3c95e59554, content=pending review已经六天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/49E1220F4F23D52CFAD7CD6EFB4CD4A2/100, createdBy=97fc2126613, createdName=吹散的天空, createdTime=Fri Apr 16 15:20:06 CST 2021, time=2021-04-16, status=1, ipAttribution=)]

2021-04-16 吹散的天空

pending review已经六天了

101 8

展开8条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务